期刊文献+

载Fe_3O_4及液态氟碳高分子纳米粒的制备及其体外相变与双模态显影 被引量:3

Preparation of Fe_3O_4/PLGA/Perfluorohexane nanoparticles and its phase transformation in vitro for enhancing ultrasound and MR imaging
下载PDF
导出
摘要 目的探讨载Fe3O4同时包裹液态全氟己烷(PFH)的高分子造影剂的制备并评价其体外相变与双模态显影能力。方法采用乳化法制备可相变的磁性造影剂,检测其粒径、电荷、表面形态及内部结构,对不同浓度的纳米粒溶液行MR扫描并用原子吸收光谱法测量各样品中Fe浓度;用加热法激发纳米粒相变,显微镜观察相变后产生的微泡,在造影模式下观察造影剂相变后增强超声显影能力。结果成功制备出可相变磁性Fe3O4/聚乳酸/羟基乙酸[PLGA]/PFH纳米粒。体外MR显像表明其能明显降低T2*WI信号强度。当加热5min温度升高至55~65℃,纳米粒相变产生微泡,且可明显增强超声显影。结论制备的可相变磁性造影剂能明显降低T2*WI信号强度,加热可发生相变,增强超声显影,可为多模态成像技术的发展奠定一定的实验基础。 Objective To prepare a perfluorohexane(PFH)-loaded phase-shift magnetic poly laetide-co-glycolide acid(PLGA)-nanoparticles,and explore its ability of phase transformation for enhancing dual-mode imaging in vitro.Methods Fe3O4/PLGA/PFH nanoparticles were prepared by modified emulsion method.The characteristics of nanoparticles(size distribution,Zeta potential and the morphology)were further examined.The nanoparticles of different concentrations were used for MR scanning,and the corresponding iron concentration was calculated.Temperature rise were applied to facilitate the phase transformation of nanoparticles.The microbubbles generated from the Fe3O4/PLGA/PFH nanoparticles were observed with the ultrasound in contrast mode.Results Fe3O4/PLGA/PFH nanoparticles for ultrasound and MR imaging were successfully prepared,which effectively decreased T2 signal.The MRI signal intensity decreased along with iron concentration increment.The Fe3O4/PLGA/PFH nanoparticles would undergo phase transformation and generate microbubbles after heated for 5min at 55—65℃.The generated microbubbles enhanced ultrasound imaging.Conclusion The developed phase-shift magnetic polymericnanoparticles can effectively decrease T2*signal,which can be used as MRI contrast agent.Besides,the nanoparticles can produce microbbules and enhance ultrasound imaging after phase transformation.Therefore,it establishes the foundation for multi-mode imaging system.
出处 《中国医学影像技术》 CSCD 北大核心 2015年第4期483-487,共5页 Chinese Journal of Medical Imaging Technology
基金 国家自然科学基金(81227801 81130025 81270021) 重庆市高校创新团队计划(KJTD201303)
关键词 磁共振成像 相变 纳米粒 超声检查 造影剂 Magnetic resonance imaging Phase-transition Nanoparticles Ultrasonography Contrast agent
  • 相关文献

参考文献14

  • 1Li A, Zheng Y, Yu J, et al. Superparamagnetic perfluorooctyl- bromide nanoparticles as a multimodal contrast agent for US, MR, and CT imaging. Acta Radiol, 2013,54(3) :278-283.
  • 2Niu C, Wang Z, Lu G, et al. Doxorubicin loaded superparamag- netic PLGA-iron oxide multifunctional microbubbles for dual- mode US/MR imaging and therapy of metastasis in lymph nodes. Biomaterials, 2013,34(9) : 2307-2317.
  • 3沈红霞,郑元义,周洋,赵建龙,罗银灯,王志刚.包裹液态氟碳的高分子超声造影剂的制备及体外显影实验[J].中国介入影像与治疗学,2012,9(4):291-294. 被引量:11
  • 4Huang J, Xu JS, Xu RX, Heat-sensitive microbubbles for intrao- perative assessment of cancer ablation margins, Biomaterials, 2010,31 (6) : 1278-1286.
  • 5Zhou Y, Wang Z, Chen Y, et al. Microbubbles from gas-genera ting perfluorohexane nanoemulsions for targeted temperature-sen sitive ultrasonography and synergistic HIFU ablation of tumors Adv Mater, 2013,25(30) :4123-4130.
  • 6Wang X, Chen H, Chen Y, et al. Perfluorohexane-encapsulated mesoporous silica nanocapsules as enhancement agents for highly efficient high intensity focused ultrasound (HIFU). Adv Mater, 2012,24(6) :785-791.
  • 7Xu S, Zong Y, Li W, et al. Bubble size distribution in acoustic droplet vaporization via dissolution using an ultrasound wide-beam method. Ultrason Sonochem, 2014,21 (3) : 975-983.
  • 8周洋,周鸿,叶鸣,王志刚.相变型液态氟碳纳米粒造影剂的制备及相变超声显影研究[J].临床超声医学杂志,2014,16(10):649-652. 被引量:7
  • 9Strohm E, Rui M, Gorelikov I, et al. Vaporization of perfluoro- carbon droplets using optical irradiation. Biomed Opt Express, 2011,2(6) : 1432-1442.
  • 10Kim J, Park S, Lee JE, et al. Designed fabrication of multifunc tional magnetic gold nanoshells and their application to magnetic resonance imaging and photothermal therapy. Angew Chem, 2006,118(46) :7918-7922.

二级参考文献20

  • 1冉海涛,任红,王志刚,郑元义,张群霞,许川山.自制高分子聚合材料超声造影剂显影效果动物实验研究[J].中华超声影像学杂志,2006,15(5):378-380. 被引量:11
  • 2Diaz-Lopez R. Tsapis N. Fattal KLiquid perfluorocarbons as contrast agenls for ultrasonography and (19)F-MRI.Pharm Res,2010.27(1): 1-16.
  • 3Zhou Y.Wang Z.Chen Y.('I al. Microbubble, from gas-generaling perfluorohexane nanoemulsions for targeted temperature =sensitive ultrasonography and synergistic HIFU ablation of tumors, Adv Mater. 2013 .25( 30 ):4123-4130.
  • 4Matsunaga TO ? Sheeran PS, l.uois S .et al.Phase-change nanoparticles using highly volatile perfluomcarbons : toward a platform for extravascular ultrasound imaging.Theranostics.2012. 2( 12): 1185-1198.
  • 5LO AH. Kripfgans OD, Carson PL, et al.Acoustic droplet vaporization threshold: effects of pulse duration and contrast tagent.lEEE Trans lJltrason Ferroelectr Freq Control.2007 ,54( 5): 933-946.
  • 6Hapoport N.Nam KH.Gupla R.et al.Ultrasound=mediated tumor imaging and nanotherapy using drug loaded. block copolymer stabilized perfluorocarhon nunoemulsions.] Control Release,2011 , IS3( I ) :4-15.
  • 7Ye T. Bull JI"Microbubble expansion in a flexible tuhe.J Biomech Eng. 2006.128(4) :554-563.
  • 8Cavalieri F. Zhau M. Ashokkumar M .The design of multifunctional microbubhles for ultrasound image -guided cancer therapy.Curr Top Med Chem.2010.10( 12): 1198-1210.
  • 9Gross U,Rudiger S,Reichelt H. Perfluorocarbons:Chemically inert but biologically active[J].Journal of Fluorine Chemistry,1991,(02):155-161.
  • 10Wickline SA,Hughes M,Ngo FC. Blood contrast enhance ment with a novel,non-gaseous nanoparticle contrast agent[J].Academic Radiology,2002,(Suppl 2):S290-S293.

共引文献15

同被引文献47

  • 1Gramiak R,Shah PM.Echocardiography of the aortic root.Invest Radiol,1968,3(5):356-366.
  • 2Mousnier L,Huang N,Morvan E,et al.Influence of polymer end-chemistry on the morphology of perfluorohexane polymeric microcapsules intended as ultrasound contrast agents.Int J Pharm,2014,471(1-2):10-17.
  • 3Zheng Y,Zhang Y,Ao M,et al.Hematoporphyrin encapsulated PLGA microbubble for contrast enhanced ultrasound imaging and sonodynamic therapy.J Microencapsul,2012,29(5):437-444.
  • 4Figueiredo M,Esenaliev R.PLGA nanoparticles for ultrasoundmediated gene delivery to solid tumors.J Drug Deliv,2012(2090-3014):767839.
  • 5Hou Z,Li L,Zhan C,et al.Preparation and in vitro evaluation of an ultrasound-triggered drug delivery system:10-hydroxycamptothecin loaded PLA microbubbles.Ultrasonics,2012,52(7):836-841.
  • 6Teng Y,Bai M,Sun Y,et al.Enhanced delivery of PEAL nanoparticles with ultrasound targeted microbubble destruction mediated siRNA transfection in human MCF-7/S and MCF-7/ADR cells in vitro.Int J Nanomedicine,2015,10:5447-5457.
  • 7Deng L,Li L,Yang H,et al.Development and optimization of doxorubicin loaded poly(lactic-co-glycolic acid)nanobubbles for drug delivery into HeLa cells.J Nanosci Nanotechnol,2014,14(4):2947-2954.
  • 8Chen H,Liu X,Don Y,et al.A pH-responsive cyclodextrinbased hybrid nanosystem as a nonviral vector for gene delivery.Biomaterials,2013,34(16):4159-4172.
  • 9Luo B,Liang H,Zhang S,et al.Novel lactoferrin-conjugated amphiphilic poly(aminoethyl ethylene phosphate)/poly(L-lactide)copolymer nanobubbles for tumor-targeting ultrasonic imaging.Int J Nanomedicine,2015,10:5805-5817.
  • 10Unger EC,Matsunaga TO,Mccreery T,et al.Therapeutic applications of microbubbles.Eur J Radiol,2002,42(2):160-168.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部